Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Update on Clinical Trials in Dysphagia

Abstract

Randomized clinical trials (RCTs) are often known as the gold standard in treatment efficacy studies. This article defines the characteristics of RCTs and the factors that investigators must consider in designing clinical trials in dysphagia. Design issues unique to behavioral treatments often used in dysphagia are discussed. Ongoing RCTs in dysphagia are described including studies of (1) the effectiveness of the Shaker exercise versus standardized treatment in patients with severe dysphagia resulting from stroke or treatment for head and neck cancer who have been nonoral for at least three months; (2) the comparative effects of nectar- and honey-thickened liquids versus chin tuck posture and in patients with dementia or Parkinson’s disease with or without dementia who aspirate on thin liquids; and (3) the comparative effects of muscle exercise versus sensory postural therapy for dysphagia resulting from treatment for head and neck cancer. Issues in generalizing from the results of clinical trials are also described.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Logemann JA: Evidence-based practice. Speech Lang Pathol (Aust) 6(2): 134–135, 2004

  2. 2.

    Logemann JA: Evidence-based practice: What, how, and why. ASHA Sp Interest Div 16 News 5(3):7–8, 2004

  3. 3.

    Sackett DL, Haynes RB: Education and debate. Evidence base of clinical diagnosis: the architecture of diagnostic research... second in a series of five articles. BMJ 324(7335): 539–541, 2002

  4. 4.

    American Academy of Neurology: Assessment: Melodic intonation therapy. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 44:566–568, 1994

  5. 5.

    DeJong G: Toward an evidence-based rehabilitation culture. Rehabil Outlook 4(2):1, 10–11, 1999

  6. 6.

    Logemann JA, Rademaker AW, Pauloski BR, Kahrilas PJ: Effects of postural change on aspiration in head and neck surgical patients. Otolaryngol Head Neck Surg 110:222–227, 1994

  7. 7.

    Rasley A, Logemann JA, Kahrilas PJ, Rademaker AW, Pauloski BR, Dodds WJ: Prevention of barium aspiration during videofluoroscopic swallowing studies: Value of change in posture. AJR Am J Roentgenol 160:1005–1009, 1993

  8. 8.

    Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA: Super-supraglottic swallow in irradiated head and neck cancer patients. Head Neck 19:535–540, 1997

  9. 9.

    Martin-Harris B, Logemann JA, McMahon S, Schleicher M, Sandidge J: Clinical utility of the modified barium swallow. Dysphagia 15:136–141, 2000

  10. 10.

    Waters TM, Logemann JA, Pauloski BR, Lazarus CL, Newman LA, Hamner AK: Beyond efficacy and effectiveness: Conducting economic analyses during clinical trials. Dysphagia 19:109–119, 2004

  11. 11.

    Jacobs J, Logemann J, Pajak TF, Pauloski BR, Collins S, Casiano RR, Schuller DE: Failure of cricopharyngeal myotomy to improve dysphagia following head and neck cancer surgery. Arch Otolaryngol Head Neck Surg 125:942–946, 1999

  12. 12.

    Logemann JA: Editorial: The need for clinical trials in dysphagia. Dysphagia 13:10–11, 1998

  13. 13.

    Logemann JA: Assessing the efficacy of our dysphagia treatments: The role of clinical trials. ASHA Sp Interest Div 13 News 9(2):4–5, 2000

  14. 14.

    Rademaker AW, Pauloski BR, Logemann JA, Shanahan TK: Oropharyngeal swallow efficiency as a representative measure of swallowing function. J Speech Hear Res 37:314–325, 1994

  15. 15.

    Robbins JA, Hind J, Logemann J: An ongoing randomized clinical trial in dysphagia. J Commun Disord 37:425–435, 2004

  16. 16.

    Baum HM, Logemann JA: Development and conduct of clinical trials in allied health professions: The communication disorders experience. J Allied Health 30(3):176–179, 2001

  17. 17.

    Baum HM, Logemann JA, Lilienfeld D: Clinical trials and their application to communication sciences and disorders. J Med Speech Lang Pathol 6:55–64, 1998

  18. 18.

    Baum HM, Logemann JA, Stenzel BA: Initiating a clinical trials cooperative group in an increasingly managed care environment: Successes and problems in establishing collaboration. Med Care Res Rev 56(Suppl 2):139–152, 1999

  19. 19.

    Homs MY, Wahab PJ, Kuipers EJ, Steyerberg EW, Grool TA, Haringsma J, Siersema PD: Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: A randomized trial. Gastrointest Endosc 60(5):695–702, 2004

  20. 20.

    Logemann JA: Clinical Trials: CSDRG overview. J Commun Disord 37:419, 2004

  21. 21.

    Logemann JA, Baum HM, Robbins J: Conducting clinical trials in a constantly changing health care environment. J Ambul Care Manage 24(2):60–68, 2001

Download references

Author information

Correspondence to Jeri A. Logemann PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Logemann, J.A. Update on Clinical Trials in Dysphagia. Dysphagia 21, 116–120 (2006). https://doi.org/10.1007/s00455-006-9017-8

Download citation

Keywords

  • Clinical trials
  • Dysphagia
  • Central laboratory
  • Swallowing
  • Parkinson’s disease
  • Dementia
  • Deglutition
  • Deglutition disorders